From one piece Manufacturing requirements are killing cell and gene therapy 2 beliefs, in the piece's order there
-
Their words
Until manufacturing and regulatory risks become easier to underwrite, capital will keep drifting away from one of the most promising technologies of the last century.
-
korrents.com
Manufacturing and batch-release requirements, not biology, are what kill most promising cell and gene therapies.Their words
Excessive manufacturing requirements are a pervasive problem, especially in the field of cell and gene therapy and they are killing countless of promising medicines before they ever reach patients.